Abstract
In early 1978, more than 42,000 Americans were sustained by maintenance hemodialysis at an annual cost for the nation in excess of 1100 million dollars. Elsewhere in this book are considerations of the benefits and limitations of the suboptimal correction of uremia permitted by dialytic therapy. There is substantial reason to attempt to shorten the duration and (or) lessen the frequency of regular hemodialysis treatments. A reduction of two hours from each dialysis, for example, might lower overall dialysis cost in the USA by about 200 million dollars while permitting increased patient’s working capabilities. Among the investigational approaches to reduce dialysis duration is the attempt to exploit the intestine’s ability to transfer nitrogenous solutes from blood to lumen. If such flux contains significant quantities of the “right” compounds then intermittent removal by lavage or adsorption would have clinical importance.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Pendleton WR, West FE: The passage of urea between the blood and the lumen of the small intestine. Am J Physiol 101: 391, 1932
Hessel G. Pekelis E. Meitzer H: Untersuchungen über die Ausscheidung harnfähiger Stoffe in den Magendarmkanal bei nephrektomierten Hunden. I, II, III, IV, and V. Z ges exp Med 91:267, 1933 (cited in ref 3)
Seligman AM, Frank HA, Fine J: Treatment of experimental uremia by means of peritoneal irrigation. J Clin Invest 25: 211, 1946
Vermooten V, Hare DM: The use of continuous gastric lavage in the treatment of uraemia associated with prostatism. J Urol 59: 907, 1948
Maluf N Sr: Intestinal and gastric perfusion in a patient with severe chronic uremia. J Urol 64: 268, 1950
Kolff WJ: New Ways of Treating Uraemia. London, JA Churchill, 1947
Twiss EE, Kolff WJ: Treatment of uremia by perfusion of isolated intestinal loop. JAMA 146: 1019, 1951
White BH, Harkins HN: The treatment of experimental uremia by intestinal lavage. Surgery 24: 90, 1948
Schloerb PR: The management of uremia by perfusion of an isolated jejunal segment. J Clin Invest 37: 1818, 1958
Quinton W, Dillard D, Scribner BH: Cannulation of blood vessels for prolonged hemodialysis. Trans Am Soc Artif Intern Organs 6: 104, 1960
Clark JE, Templeton JY III, McCurdy DK: Perfusion of isolated intestinal loops in the management of chronic renal failure, Trans Am Soc Artif Intern Organs 8: 246, 1962
Pateras VR, Dossetor J, Gault MH, Hells SJ, Yagushi Y, Mackinnon KJ: The role of intestinal perfusion in the management of chronic uremia. Trans Am Soc Artif Intern Organs 10: 292, 1964
Sparks RE: Gastrosorbents in the therapy of uremia; inferences from intestinal loop dialysis. Kidney Int 7: S373, 1975
Thompson WS, Lewis JJ, Alving AS: Physiological changes during perfusion of the isolated intestinal loop in chronic uremia. J Lab Clin Med 39: 69, 1952
Pyrah LN, Care AD: The use of an isolated loop of ileum as an auxiliary kidney. Br J Urol 29: 45, 1957
Orlowski T, Ajewski Z, Rymkiewicz H, Sicinski A: A trial of treatment of chronic renal insufficiency by lavage of an isolated intestinal loop. Pol Arch Med Wewn 31:857, 1961 (cited in ref 32)
Rasanen T: The treatment of chronic renal failure with lavage of the separated intestinal loop. Acta Chir Scand 126: 233, 1963
Parisi R, Stephen RL: Isolated jejunal loop dialysis in the management of chronic renal failure. Med J Aust 1: 100, 1972
Hagstam KE, Larsson LE, Thysell H: Experimental studies on charcoal haemoperfusion in phenobarbital intoxication and uraemia, including histopathologic findings Acta Med Scand 180: 593, 1966
Williams R, Gazzard BG, Weston MJ, Murray-Lyon IM, Flax H, Record CO, Portmann B, Langley PG, Dunlop EH, Mellon PJ, Ward MB: Charcoal haemoperfusion in the treatment of fulminant hepatic failure. Lancet 1: 1301, 1974
Harrison SD, Davis TA, Cowsar DR, Tanquary AC: An improved hemoperfusion device for treatment of drug intoxication. Fed Proc (Abstract) 33: 527, 1974
Davis TA: Activated carbon fibers in hemoperfusion devices. Kidney Int 7: S406, 1975
Bergström J, Fürst P: Uremic middle molecules. Clin Nephrol 5: 143, 1976
Winchester JF, Apiliga MT, Mackay JM, Kennedy AC: Haemodialysis with charcoal haemoperfusion. Proc Eur Dial Transpl Assoc 12: 526, 1975
Yatzidis H: Recherches sur l’épuration extrarénale à l’aide du charbon actif. Nephron 1: 310, 1964
Denti E, Luboz MP, Tessore VA, Castino F, Gaglia PF: Adsorbents in hemoperfusion. Kidney Int 7: S401, 1975
Maxwell MH, Gordon A, Greenbaum M: Oral sorbents in medicine. In Uremia, edited by Kluthe R, Berlyne G, Burton B, Stuttgart, Georg Thieme Verlag, 1972, p 720
Gardner DL, Emmerling DC, Williamson KD, Baytos WC, Hassler CR: Encapsulated adsorbents for removal of nitrogenous metabolites via oral ingestion. Kidney Int 7: S393, 1975
Giordano C, Esposito R, Randazzo G: Oxystarch as a gastrointestinal sorbent in uremia. In Uremia edited by Kluthe R, Berlyne G, Burton B, Stuttgart, Georg Thieme Verlag, 1972, p 231
Giordano C, Esposito R, Pluvio M: The effects of oxidised starch on blood and faecal nitrogen in uraemia. Proc Eur Dial Transpl Assoc 10: 136, 1973
Giordano C, Esposito R: Studies on oxystarch and uremia. Proc 8th Annual Contractors’ Conf Artificial Kidney Program, NIAMDD, edited by Mackey BB, DHEW publ no (NIH) 76–248, 1975, p 125
Sparks RE, Mason NS, Meier PM, Litt MH, Lindan O: Removal of uremic waste metabolites from the intestinal tract by encapsulated carbon and oxidized starch. Trans Am Soc Artif Intern Organs 17: 229, 1971
Friedman EA, Fastook J, Beyer MM, Rattazzi T, Josephson AS: Potassium and nitrogen binding in the human gut by ingested oxidized starch (OS). Trans Am Soc Artif Intern Organs 20: 161, 1974
Man NK, Drueke T, Paris J, Elizalde Monteverde C, Rondon Nucete M, Zingraff J, Jungers P: Increased nitrogen removal from the intestinal tract of uraemic patients. Proc Eur Dial Transpl Assoc 10: 143, 1973
Friedman EA, Laungani GB, Beyer MM: Life prolongation in nephrectomized rats fed oxidized starch and charcoal: Kidney Int 7: S377, 1975
Saltzman MJ, Beyer MM, Friedman EA: Mechanism of life prolongation in nephrectomized rats treated with oxidized starch and charcoal. Kidney Int 10:S 7 – 343, 1977
Friedman EA, Saltzman MJ, Beyer MM, Josephson AS: Combined oxystarch-charcoal trial in uremia: Sorbent-induced reduction in serum cholesterol. Kidney Int 10: S7 - 273, 1977
Goldenhersh KK, Huang W, Mason NS, Sparks RE: Effect of microencapsulation on competitive adsorption in intestinal fluids. Kidney Int 10: S7–251, 1977
Alfrey AC, LeGendre GR, Kaehny WD: The dialysis encephalopathy syndrome possible aluminium intoxication. N Engl J Med 294: 184, 1976
Jacobs C, Brunner FP, Chantler C, Donckerwolcke RA, Gurland HJ, Hathway RA, Selwood NH, Wing AJ: Combined report on regular dialysis and transplantation in Europe, VII, 1976. Proc Eur Dial Transplant Assoc 14: 2, 1977
Pierides AM, Ward MK, Kerr DNS: Haemodialysis encephalopathy: possible role of phosphate depletion. Lancet 1: 1234, 1976
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1979 Martinus Nijhoff Publishers bv, The Hague
About this chapter
Cite this chapter
Friedman, E.A. (1979). Oral Sorbents as Adjunctive Treatment in Uremia. In: Drukker, W., Parsons, F.M., Maher, J.F. (eds) Replacement of Renal Function by Dialysis. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-9327-3_13
Download citation
DOI: https://doi.org/10.1007/978-94-009-9327-3_13
Publisher Name: Springer, Dordrecht
Print ISBN: 978-90-247-2227-3
Online ISBN: 978-94-009-9327-3
eBook Packages: Springer Book Archive